Monday, June 10, 2019

SerImmune Finds $1.4M In Ongoing Funding

Santa Barbara-based SerImmune, a company developing immune mapping technology, has raised $1.4M in new funding, as part of what appears to be an ongoing $7.0M funding effort. The funding--which was disclosed via a regulatory filing--shows the round as a debt funding round, suggesting the funding is likely a convertible debt funding from existing invest

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---